Orgenesis Inc. (OTCQX:ORGS), a global biotech company focused on advancing cell and gene therapies (CGT), has secured an equity investment of up to $5 million...
Orgenesis
Orgenesis Inc. (OTCQX: ORGS), a global biotech company has recently shared its business update for the third quarter ending September 30, 2024. The company is...
